NIH-funded research NIH-funded research

Virology Core supporting hepatitis B and HIV cure research

Official title: Virology Core

Funded at Johns Hopkins University · NIH-11600461 · Data updated 2026-11-12

A Virology Core at Johns Hopkins helps test patient samples with standardized HBV assays and develops new tests to support multiple projects aimed at finding a functional cure for hepatitis B in people living with HIV and others.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 17, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$88,487
NIH project number3U19AI188551-02S3
Project IDNIH-11600461 on NIH RePORTER

Who could benefit from this research

Could help

Adults with chronic hepatitis B, including people with HIV co-infection, and control groups with hepatitis B only, across participating sites.

Less likely to help

Individuals not living with hepatitis B or HIV may not directly benefit from this core's activities.

What this research studies

This core provides high-quality virology testing on participant samples collected across global sites, focusing on hepatitis B surface antigen dynamics in people living with HIV and hepatitis B. It standardizes and optimizes assays to enable reliable data for all related projects and supports the use of lab models to advance experiments. By coordinating with the Shared Resources Core, the Virology Core helps ensure that results are timely, accurate, and usable for statistical analyses. The work aims to move toward a functional HBV cure by characterizing viral markers during treatment in diverse participant groups and controls.

Why it matters

Potential benefit: Patients could benefit from improved testing methods and rigorous data to guide strategies toward functional cure for hepatitis B in the context of HIV co-infection.

How similar studies have gone: Previous efforts have shown that standardized HBV testing and detailed virological characterization can inform cure-directed strategies, though this exact multi-site core approach is ongoing.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Thio, Chloe L — Johns Hopkins University
  • Study coordinator: Thio, Chloe L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.